- The US Food and Drug Administration has granted approval for Nourianz (istradefylline) for use as adjunctive
treatment to levodopa/carbidopa in adult patients with Parkinson's disease experiencing "OFF" episodes, Japan-based Kyowa Kirin Co., Ltd., (TYO: 4151) said.
The product is an adjunctive
treatment in patients affected by treatment-resistant depression.
Perampanel is currently approved in more than 55 countries, including the United States, Japan, in Europe and in Asia as adjunctive
treatment for partial-onset seizures (with or without secondarily generalized seizures) in patients with epilepsy 12 years of age and older.
[USA], Jan 31 (ANI): A new study now finds that smoking cannabis as an adjunctive
second-line therapy to treat chronic peripheral neuropathy can be both effective and cost-effective.
In conjunction, the paediatric exclusivity determination is based on data from the company's LYRICA Paediatric Epilepsy Programme, which were submitted in response to the US FDA's Written Request to evaluate the use of LYRICA as adjunctive
therapy for partial onset seizures in paediatric epilepsy patients.
6, 2018 (HealthDay News) -- An adjunctive
buprenorphine/samidorphan (BUP/SAM) combination seems beneficial for patients with major depressive disorder (MDD) with inadequate response to antidepressant therapy (ADT), according to a study published online Oct.
Celecoxib as adjunctive
therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial.
The decision to cut or not depends upon lesion size, shape, age, location, and--most important of all--patient commitment to the treatment process, which should always include postsurgical adjunctive
Novartis' Afinitor DISPERZ (everolimus tablets for oral suspension), has been approved by the FDA for the adjunctive
treatment of adult and pediatric patients aged two years and older with tuberous sclerosis complex (TSC)-associated partial-onset seizures.
The findings in this study show that SSRIs, adjunctive
L-Methylfolate, 15 mg/day, produced greater response rates compared with SSRIs plus placebo.
LATUDA is indicated for the treatment of major depressive episodes associated with bipolar I disorder (bipolar depression) as monotherapy and as adjunctive
therapy with lithium or valproate in adults.